Assessment of Thrombospondin-1 Level in Type II Diabetic Patients
DOI:
https://doi.org/10.36320/ajb/v7.i1.8097Keywords:
Fasting blood glucose ,Thrombospondin-1, Type II diabetic patients.Abstract
The study is intended to asses serum levels of Thrombospondin-1, fasting blood glucose in type 2 diabetic patients, also correlation between Thrombospondin-1 in both males and females.
The study was conducted on randomly selected 65 type 2 diabetic patients (34 males and 31 females) attending the diabetes mellitus center in Al-Sadder Teaching City in Al- Najaf province , Iraqi and a group of 24 apparently healthy subjects (12 Males and 12 Females) were included as a control group . The Study was carried out from August 2013 to February 2014.The patients' age was ranging from 35 to 64 years old.
The results indicated a significant increase (p<0.05) in serum FBG and TSP-1 levels in diabetic patients in comparing with healthy groups.
The results also revealed no significant differences (p> 0.05) in serum TSP-1 levels between males and females in both patients and healthy groups, while the results of FBG levels significantly (p<0.05) increase in females than males in both patients and healthy groups.
The results have been shown significant positive correlation (P<0.05) between TSP-1 and FBG in (males and females), males, females DM patients.
The present study concluded that Thrombospondin-1 were marker for detection and diagnosis of diabetic patients type 2.
Downloads
References
Canadian Diabetes Association (CDA). (2008). Clinical Practice Guideline for the Prevention and Management of Diabetes in Canada. Canad. J. Diabet., 32(1):S1-S201.
Alemzadeh, R. ;Wyatt, D.T.; Behrman, R.E.; Kliegman, R.M. and Jenson, H.B. (2008). Diabetes mellitus in children. Nelson Textbook of Pediatrics. 18th ed. Philadelphia: Saunders., PP : 2404-31.
Thabrew, I. and Ayling, R.M. (2001). Biochemistry for clinical Medicine. 1st ed. Green wich Medical Media ttd. London. Pp.166-167.
Leahy; Jack, L. and William, T. (2002). insulin Therapy. 1st ed. New York: Marcel Dekker. ISBN.0-8247-0711-7. DOI: https://doi.org/10.1201/b14038
Qian, X.; Tuszynski, G.P.(1996). Expression of thrombospondin-1 in cancer: A role in tumor progression. Proc. Soc. Exp. Biol. Med., 212: 199–207. DOI: https://doi.org/10.3181/00379727-212-44008
Taraboletti, G.; Roberts, D.D.; Liotta, L.A.; Giavazzi, R.(1990). Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor. J. Cell Biol., 111: 765–772. DOI: https://doi.org/10.1083/jcb.111.2.765
Tolsma, S.S.; Stack, M.S.; Bouck, N.(1997). Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thorombospondin-1. Microvasc. Res., 54:13–26. DOI: https://doi.org/10.1006/mvre.1997.2015
Jimenez, B.; Volpert, O.V.; Crawford, S.E.; Febbraio, M.; Silverstein, R.L. and Bouck, N. (2000). Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med., 6: 41-48. DOI: https://doi.org/10.1038/71517
Lawler, J. (2002). Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J. Cell Mol. Med., 6:1-12. DOI: https://doi.org/10.1111/j.1582-4934.2002.tb00307.x
Armstrong, L.C.; Bormstein, P.(2003). Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol., 22: 63–71. DOI: https://doi.org/10.1016/S0945-053X(03)00005-2
Adams, J.C., and Lawler, J. (2004). The thrombospondins. Int. J. Biochem. Cell Biol., 36:961-968. DOI: https://doi.org/10.1016/j.biocel.2004.01.004
Lawler, J.(2000). The functions of TSP-1 and TSP-2. Curr. Opin. Cell Biol., 12: 634–650. DOI: https://doi.org/10.1016/S0955-0674(00)00143-5
Isenberg, J.S.; Martin-Manso, G.; Maxhimer, J.B.; Roberts, D.D. (2009).Regulation of nitric oxide signaling by thrombospondin-1: Implications for anti-angiogenic therapies. Nat. Rev. Cancer, 9: 182–194. DOI: https://doi.org/10.1038/nrc2561
Reed, M.J.; Puolakkainen, P.; Lane, T.F.; Dickerson, D.; Bornstein, P.; Sage, E.H.(1993). Different expression of SPARC and thrombospondin-1 in wound repair. Immunolocalization and in situ hybridization. J. Histochem. Cytochem., 41: 1467–1477. DOI: https://doi.org/10.1177/41.10.8245406
Bauer, E.M. ; Qin, Y.; Miller, T.W. ; Bandle, R.W. ; Csanyi, G. ; Pagano, P.J. ; Bauer, P.M. ; Schnermann, J. ; Roberts, D.D. ; Isenberg, J.S. (2010).Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc. Res., 88:471–481. DOI: https://doi.org/10.1093/cvr/cvq218
Lopez-Dee, Z.; Pidcock, K.; Gutierrez, L.S. (2011). Thrombospondin-1: Multiple paths to inflammation. Mediators Inflamm.,1-10. DOI: https://doi.org/10.1155/2011/296069
Al-Rawi, K.(2000). Entrance to the Statistics. Second edition. Faculty of Agriculture and Forestry, University of Mosul.
National Diabetes Information Clearinghouse (NDIC).(2008). National Diabetes Statistics.
Ismail, B.H.(2010). Comparison Study of insulin level and lipid profile in diabetes mellitus in Ramadi city. J. of university of Anbar for pure .sci.,4(2):1-3. DOI: https://doi.org/10.37652/juaps.2010.43916
Paz ,V. ; Elena , L. and Marcia, H. (2006).Sexual dimorphism in insulin sensitivity and susceptibility to develop diabetes in rats. J. End., 190:425-432. DOI: https://doi.org/10.1677/joe.1.06596
Khan, H.A. (2006). Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients. Acta. Diabet.,1-8.
Haffner, S.M.; Lehto, S.; Ronnemaa, T.; Pyorala, K.; Laakso, M. (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med., 339:229–234. DOI: https://doi.org/10.1056/NEJM199807233390404
Gu, K. ; Cowie, C.C. and Harris, M.I. (1999). Diabetes and decline in heart disease mortality in US adults. JAMA., 281:1291–1297. DOI: https://doi.org/10.1001/jama.281.14.1291
Steinberg, H.O.; Paradisi, G.; Cronin, J.; Crowde, K. ; Hempfling, A. ;Hook, G. and Baron, A.D. (2000). Type II diabetes abrogates sex differences in endothelial function in pre-menopausal women. Circul., 101:2040–2046. DOI: https://doi.org/10.1161/01.CIR.101.17.2040
Stenina, O.I.; Krukovets, I.; Wang, K.; Zhou, Z.; Forudi, F.; Penn, M.S. et al.(2003). Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat. Circul, 107:3209-15. DOI: https://doi.org/10.1161/01.CIR.0000074223.56882.97
Kong, P.; Gonzalez-Quesada, C.; Li, N.; Cavalera, M.; Lee, D.W. and Frangogiannis, N.G.(2013a). Thrombospondin-1 regulates adiposity and metabolic dysfunction in dietinduced obesity enhancing adipose inflammation and stimulating adipocyte proliferation. Am. J. Physiol. Endocrinol. Metab., 305:E439-50. DOI: https://doi.org/10.1152/ajpendo.00006.2013
Raman, P.; Krukovets, I.; Marinic, T.E.; Bornstein, P. and Stenina, O.I.(2007).Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells. J. Biol. Chem., 282:5704-14. DOI: https://doi.org/10.1074/jbc.M610965200
Raman, P.; Harry, C.; Weber, M.; Krukovets, I. and Stenina, O.I.(2011). A novel transcriptional mechanism of cell type specific regulation of vascular gene expression by glucose. Arterioscler. Thromb. Vasc. Biol., 31: 634-42. DOI: https://doi.org/10.1161/ATVBAHA.110.219675
Yung, S. ; Candice, Y.Y. ; Lee, Y. ; Zhang, L. Q. ; Lau, S.K. ; Tsang, R.C.W. and Chan, T.M. (2006). Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-b1 dependent and TGF-b1 independent pathways. Nephrol. Dial. Transplant, 21: 1504–1513. DOI: https://doi.org/10.1093/ndt/gfl017
Tang, M. ; Zhou, F. ; Zhang, W. ; Guo, Z. ;Shang Y. ; Lu, H. ; Lu, R. ; Zhang, Y. ; Chen, Y. and Zhong, M. (2011).The role of thrombospondin1-mediated TGF-b1 on collagen type III synthesis induced by high glucose. Mol.Cell. Biochem., 346:49–56. DOI: https://doi.org/10.1007/s11010-010-0590-7
Murphy-Ullrich, J.E. and Poczatek, M.(2000). Activation of latent TGF-beta by thrombospondin1: mechanisms and physiology. Cytok. Grow. Fact. Rev., 11: 59–69. DOI: https://doi.org/10.1016/S1359-6101(99)00029-5
Yevdokimova, N. ; Wahab, N.A. and Mason, R.M.(2001). Thrombospondin-1 is the key activator of TGF-b1 in human mesangial cells exposed to high glucose. J. Am. Soc. Nephrol., 12: 703–712. DOI: https://doi.org/10.1681/ASN.V124703
Kong, P. ; Cavalera, M. and Frangogiannis, N.G.(2013b). The role of thrombospondin-1 (TSP-1) in obesity and diabetes. Adipocyte , 3:1:1-4. DOI: https://doi.org/10.4161/adip.26990
Sheibani, N.; Sorenson, C.M.; Cornelius, L.A. and Frazier, W.A. (2000). Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia. Biochem. Biophys. Res. Commun., 267: 257-261. DOI: https://doi.org/10.1006/bbrc.1999.1903
Wang, S.; Gottlieb, J.L. ; Sorenson, C.M. and Sheibani, N. (2009). Modulation of thrombospondin-1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes. Arch. Ophthalmol., 127: 507-513. DOI: https://doi.org/10.1001/archophthalmol.2009.53
Varma, V.; Yao-Borengasser, A.; Bodles, A.M.; Rasouli, N.; Phanavanh, B. et al.(2008). Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabet., 57: 432–439. DOI: https://doi.org/10.2337/db07-0840
Li ,Y. ; Tong, X. ; Rumala, C. ; Clemons, K. and Wang, S. (2011). Thrombospondin1 deficiency reduces obesity-associated inflammation and improves insulin sensitivity in a diet-induced obese mouse model. PLoS. One. , 6: e26656. DOI: https://doi.org/10.1371/journal.pone.0026656
Voros, G. and Lijnen, H.R. (2006). Deficiency of thrombospondin-1 in mice does not affect adipose tissue development. J. Thromb. Haemost., 4: 277–278. DOI: https://doi.org/10.1111/j.1538-7836.2005.01696.x
Winzer, C. ;Wagner, O.; Festa, A. et al.(2004). Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabet. Care, 27: 1721-7. DOI: https://doi.org/10.2337/diacare.27.7.1721
Belmadani, S.; Bernal, J.; Wei, C.C.; Pallero, M.A.; Dell’italia, L.; Murphy-Ullrich, J.E. and Berecek, K.H. (2007). A thrombospondin-1antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. Am. J. Pathol., 171(3):777–789. DOI: https://doi.org/10.2353/ajpath.2007.070056
Ramis, J.M.;Franssen-van Hal, N.L.; Kramer, E.; Llado, I.; Bouillaud, F. et al. (2002).Carboxypeptidase E and thrombospondin-1 are differently expressed in subcutaneous and visceral fat of obese subjects. Cell. Mol. Life Sci., 59: 1960- 1971. DOI: https://doi.org/10.1007/PL00012518
Hajri , T.; Han ,X.X.; Bonen, A. and Abumrad, N.A.(2002). Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J. Clin. Invest., 109:1381-9. DOI: https://doi.org/10.1172/JCI0214596
Hajri, T.; Hall, A.M.; Jensen, D.R.; Pietka, T.A.; Drover, V.A.; Tao, H.; Eckel, R. and Abumrad, N.A.(2007). CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue. Diabet., 56: 1872-80. DOI: https://doi.org/10.2337/db06-1699
Hida, K.; Wada, J.; Zhang, H.; Hiragushi, K.; Tsuchiyama, Y.; Shikata, K. and Makino, H.(2000). Identification of genes specifically expressed in the accumulated visceral adipose tissue of OLETF rats. J. Lipid Res., 41:1615–1622. DOI: https://doi.org/10.1016/S0022-2275(20)31994-5
Wahab, N.A.; Schaefer, L.; Weston, B.S. et al.(2005).Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabet., 48: 2650–2660. DOI: https://doi.org/10.1007/s00125-005-0006-5
Maier, G.M. ; HAN, X. ; Sadowitz, B.; Gentile, K.L.; Middleton, F.A. and Gahton, V. (2009). Thrombospondin-1: A proatherosclerotic protein augmented by hyperglycemia. J. Vas. Surg., 51(5):1238-1247. DOI: https://doi.org/10.1016/j.jvs.2009.11.073
Adams, J.C. (1997). Thrombospondin-1. Int. J. Biochem. Cell. Biol., 29: 861-865. DOI: https://doi.org/10.1016/S1357-2725(96)00171-9
Maile, L. A.; Capps, B. E.; Miller, E. C. ; Aday, A. W. and Clemmons, D. R. (2008). “Integrin-associated protein association with src homology 2 domain containing tyrosine phosphatase substrate 1 regulates IGF-i signaling in vivo,” Diabet ., 57(10): 2637–2643. DOI: https://doi.org/10.2337/db08-0326
Chen, H.; Sottile, J. ; Strickland, D. K. and Mosher, D. F. (1996a). Binding and degradation of thrombospondin-1 mediated through heparan sulphate proteoglycans and low-densitylipoprotein receptor-related protein: localization of the functional activity to the trimeric N-terminal heparin-binding region of thrombospondin-1. Biochem. J., 318(3): 959–963. DOI: https://doi.org/10.1042/bj3180959
Chen, H. ; Strickland, D. K. and Mosher, D. F.(1996b). Metabolism of thrombospondin-2: binding and degradation by 3T3 cells and glycosaminoglycan-variant Chinese hamster ovary cells. J . Biol. Chem., 271 (27):15993– 15999. DOI: https://doi.org/10.1074/jbc.271.27.15993
Hong, H. ; Liu, L. P. ; Liao, J. M. et al.(2009). Downregulation of LPR1 at the blood-brain barrier in streptozotocin-induced diabetic mice. Neuropharmacol ., 56(6-7) 1054–1059. DOI: https://doi.org/10.1016/j.neuropharm.2009.03.001
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Wijdan Rajh Hamza Al-Kraity, Arshad Noori Ghani Al-Dugaili
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
